Targeting cAMP in chronic lymphocytic leukemia: a pathway-dependent approach for the treatment of leukemia and lymphoma

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.17, Iss.8, 2013-08, pp. : 937-949

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bendamustine for treatment of chronic lymphocytic leukemia

By Chang Julie Elizabeth Kahl Brad Steven

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 10, 2012-07 ,pp. : 1495-1505

Informa Healthcare

Access to resources Recommend Favorite

Targeting Signaling Pathways in Chronic Lymphocytic Leukemia

Current Cancer Drug Targets, Vol. 16, Iss. 8, 2016-09 ,pp. : 669-688

Bentham Science Publishers

Access to resources Recommend Favorite

New treatment options for chronic lymphocytic leukemia

By Delgado Julio Baumann Tycho Santacruz Rodrigo Montserrat Emili

Expert Opinion on Pharmacotherapy, Vol. 15, Iss. 6, 2014-04 ,pp. : 823-832

Informa Healthcare

Access to resources Recommend Favorite

Novel Monoclonal Antibodies for the Treatment of Chronic Lymphocytic Leukemia

Current Cancer Drug Targets, Vol. 8, Iss. 2, 2008-03 ,pp. : 156-171

Bentham Science Publishers

Access to resources Recommend Favorite

Pentostatin in chronic lymphocytic leukemia

By Sauter Craig Lamanna Nicole Weiss Mark A

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 9, 2008-09 ,pp. : 1217-1222

Informa Healthcare

Access to resources Recommend Favorite